King & Spalding is a proud sponsor of ACI’s 2nd Annual Life Sciences AI Summit on February 20th in New York City, where partners Amanda Klingler and Mark Sentenac will be featured speakers. Amanda will participate in a discussion on navigating FDA and EMA directives for AI in life sciences, and Mark will be part of a panel focusing on AI litigation and enforcement risks across the life sciences product lifecycle: from pre-commercialization to post-market.
More information can be found at: Life Sciences AI Summit